Work

Nonclinical Safety Assessment of Anti-Factor D: Key Strategies and Challenges for the Nonclinical Development of Intravitreal Biologics

Year: 2017

Type: article

Source: Journal of Ocular Pharmacology and Therapeutics

DOI: 10.1089/jop.2017.0063

Authors: Vladimir Bantseev, Rebecca Erickson, Douglas Leipold, Caroline Amaya, Paul E. Miller, Helen Booler, Evan A. Thackaberry

Institutions: Genentech, Denali Therapeutics (United States), University of Wisconsin–Madison

Language: English

Topic: Retinal Diseases and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2769257507

FWCI: 2.402

Cites: 18

Cited by: 16

Related to: 10